Indian health secretary ‘strongly disagrees’ with US trade report 02-May-2019 By Ben Hargreaves The USTR stated that 20% of medicines on the Indian market were counterfeit, a claim that the country’s health secretary labelled as an ‘opposition to low-cost generics.’